“PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY”. Voprosy onkologii 66, no. 1 (January 1, 2020): 23–28. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1051.